rs145873210

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1

The NM_004946.3(DOCK2):​c.3836C>T​(p.Thr1279Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,613,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. T1279T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00062 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

DOCK2
NM_004946.3 missense

Scores

3
16

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.799

Publications

4 publications found
Variant links:
Genes affected
DOCK2 (HGNC:2988): (dedicator of cytokinesis 2) The protein encoded by this gene belongs to the CDM protein family. It is specifically expressed in hematopoietic cells and is predominantly expressed in peripheral blood leukocytes. The protein is involved in remodeling of the actin cytoskeleton required for lymphocyte migration in response to chemokine signaling. It activates members of the Rho family of GTPases, for example RAC1 and RAC2, by acting as a guanine nucleotide exchange factor (GEF) to exchange bound GDP for free GTP. Mutations in this gene result in immunodeficiency 40 (IMD40), a combined form of immunodeficiency that affects T cell number and function, also with variable defects in B cell and NK cell function. [provided by RefSeq, May 2018]
DOCK2 Gene-Disease associations (from GenCC):
  • DOCK2 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004946.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014049262).
BP6
Variant 5-170042092-C-T is Benign according to our data. Variant chr5-170042092-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 542633.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000617 (94/152240) while in subpopulation AFR AF = 0.00176 (73/41536). AF 95% confidence interval is 0.00143. There are 0 homozygotes in GnomAd4. There are 56 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004946.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOCK2
NM_004946.3
MANE Select
c.3836C>Tp.Thr1279Met
missense
Exon 38 of 52NP_004937.1Q92608-1
DOCK2
NR_156756.1
n.3939C>T
non_coding_transcript_exon
Exon 39 of 53

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOCK2
ENST00000520908.7
TSL:2 MANE Select
c.3836C>Tp.Thr1279Met
missense
Exon 38 of 52ENSP00000429283.3Q92608-1
DOCK2
ENST00000524185.5
TSL:1
n.*791C>T
non_coding_transcript_exon
Exon 39 of 53ENSP00000428850.1E5RFJ0
DOCK2
ENST00000524185.5
TSL:1
n.*791C>T
3_prime_UTR
Exon 39 of 53ENSP00000428850.1E5RFJ0

Frequencies

GnomAD3 genomes
AF:
0.000618
AC:
94
AN:
152122
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00176
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000244
AC:
61
AN:
250154
AF XY:
0.000229
show subpopulations
Gnomad AFR exome
AF:
0.00204
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000928
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000531
Gnomad OTH exome
AF:
0.000492
GnomAD4 exome
AF:
0.000106
AC:
155
AN:
1461108
Hom.:
0
Cov.:
31
AF XY:
0.000106
AC XY:
77
AN XY:
726822
show subpopulations
African (AFR)
AF:
0.00185
AC:
62
AN:
33446
American (AMR)
AF:
0.0000448
AC:
2
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.000832
AC:
33
AN:
39652
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86208
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53318
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000378
AC:
42
AN:
1111582
Other (OTH)
AF:
0.000149
AC:
9
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000617
AC:
94
AN:
152240
Hom.:
0
Cov.:
32
AF XY:
0.000752
AC XY:
56
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00176
AC:
73
AN:
41536
American (AMR)
AF:
0.000850
AC:
13
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000402
Hom.:
1
Bravo
AF:
0.000922
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
DOCK2 deficiency (1)
-
-
1
DOCK2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.061
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.26
FATHMM_MKL
Benign
0.26
N
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.014
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.4
L
PhyloP100
0.80
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.085
Sift
Benign
0.052
T
Sift4G
Benign
0.10
T
Varity_R
0.079
gMVP
0.21
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs145873210;
hg19: chr5-169469096;
COSMIC: COSV56944791;
COSMIC: COSV56944791;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.